UCB6114
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Advanced solid tumors | A study to assess the safety, pharmacokinetics and anti tumor activity of UCB6114 administered intravenously to participants with advanced solid tumors | Phase1/2 |
ONC001
Ongoing |
NCT04393298 2019-002598-78 |
Sarker D. Cancer Research 2023; 83(8_Supplement) AACR Annual Meeting, April 14-19, 2023, Orlando, USA |